These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18958751)

  • 1. Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages.
    Brodsky RA; Jones RJ
    Autoimmunity; 2008 Dec; 41(8):596-600. PubMed ID: 18958751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases.
    DeZern AE; Petri M; Drachman DB; Kerr D; Hammond ER; Kowalski J; Tsai HL; Loeb DM; Anhalt G; Wigley F; Jones RJ; Brodsky RA
    Medicine (Baltimore); 2011 Mar; 90(2):89-98. PubMed ID: 21358440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose cyclophosphamide treatment for autoimmune disorders.
    Brodsky RA
    ScientificWorldJournal; 2002 Jun; 2():1808-15. PubMed ID: 12806171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose cyclophosphamide for aplastic anemia and autoimmunity.
    Brodsky RA
    Curr Opin Oncol; 2002 Mar; 14(2):143-6. PubMed ID: 11880702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose cyclophosphamide therapy without stem cell rescue for severe refractory autoimmune illnesses: comment on the article by Moore et al.
    Prestrud AA; Hoch S; Brodsky I; Gladstone DE
    Arthritis Rheum; 2003 May; 48(5):1463; author reply 1464-6. PubMed ID: 12746926
    [No Abstract]   [Full Text] [Related]  

  • 6. Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica.
    Burt RK; Balabanov R; Han X; Burns C; Gastala J; Jovanovic B; Helenowski I; Jitprapaikulsan J; Fryer JP; Pittock SJ
    Neurology; 2019 Oct; 93(18):e1732-e1741. PubMed ID: 31578302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation.
    Burt RK; Traynor AE; Pope R; Schroeder J; Cohen B; Karlin KH; Lobeck L; Goolsby C; Rowlings P; Davis FA; Stefoski D; Terry C; Keever-Taylor C; Rosen S; Vesole D; Fishman M; Brush M; Mujias S; Villa M; Burns WH
    Blood; 1998 Nov; 92(10):3505-14. PubMed ID: 9808541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentostatin (Nipent) and high-dose cyclophosphamide for the treatment of refractory autoimmune disorders.
    Goodman M
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):67-71. PubMed ID: 10877056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New possibilities of treating patients with autoimmune disorders].
    Gergely P; Fekete B
    Orv Hetil; 2007 Apr; 148 Suppl 1():58-62. PubMed ID: 17430796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose cyclophosphamide for autoimmunity and alloimmunity.
    Brodsky RA
    Immunol Res; 2010 Jul; 47(1-3):179-84. PubMed ID: 20087683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot trial for severe, refractory systemic autoimmune disease with stem cell transplantation.
    Leng XM; Zhao Y; Zhou DB; Situ H; Li TS; Shen T; Zhao YQ; Zeng XF; Zhang FC; Dong Y; Tang FL
    Chin Med Sci J; 2005 Sep; 20(3):159-65. PubMed ID: 16261884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
    Petri M; Jones RJ; Brodsky RA
    Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia.
    Guo Z; Gao HY; Zhang TY; Liu XD; Yang K; Lou JX; He XP; Zhang Y; Chen P; Chen HR
    Int J Hematol; 2016 Dec; 104(6):720-728. PubMed ID: 27709450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling.
    Mori T; Koh H; Onishi Y; Kako S; Onizuka M; Kanamori H; Ozawa Y; Kato C; Iida H; Suzuki R; Ichinohe T; Kanda Y; Maeda T; Nakao S; Yamazaki H
    Int J Hematol; 2016 Apr; 103(4):461-8. PubMed ID: 26910242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring.
    Openshaw H; Lund BT; Kashyap A; Atkinson R; Sniecinski I; Weiner LP; Forman S
    Biol Blood Marrow Transplant; 2000; 6(5A):563-75. PubMed ID: 11071262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
    Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K
    Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide in dermatology.
    Kim J; Chan JJ
    Australas J Dermatol; 2017 Feb; 58(1):5-17. PubMed ID: 26806212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease.
    Brodsky RA; Petri M; Smith BD; Seifter EJ; Spivak JL; Styler M; Dang CV; Brodsky I; Jones RJ
    Ann Intern Med; 1998 Dec; 129(12):1031-5. PubMed ID: 9867758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation.
    Luznik L; O'Donnell PV; Fuchs EJ
    Semin Oncol; 2012 Dec; 39(6):683-93. PubMed ID: 23206845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.